This multicenter, randomized, double-blind, placebo-controlled trial will determine the efficacy of Sabril (vigabatrin) as add-on therapy in non-refractory patients who experience occasional complex partial seizures while on carbamazepine monotherapy. The efficacy, safety and impact on quality of life of rational polytherapy with Sabril and carbamazepine.
Showing the most recent 10 out of 470 publications